CROI 2016 Program at a Glance

Program and Agenda

Session P-L3 Poster Abstracts

Hall A/B

Session P-M3 Poster Abstracts

Hall A/B

2:45 PM-4:00 PM HIV Drug Resistance in Different Drug Classes 504 Incompatibility of HIV-1 Resistance to Both Cenicriviroc and Neutralizing Antibodies

2:45 PM-4:00 PM Detecting HCV 525 Comparison of 4 HCV Viral Load Assays at High Viral Load Robert Ehret 1 ; Marcel Schütze 1 ; AndrewMoritz 1 ; HaukeWalter 2 ; Gunnar Schalasta 3 ; Annemarie Berger 4 ; Martin J. Obermeier 1 1 MedCntr for InfectiousDiseases,Berlin,Germany; 2 Medizinisches InfektiologiezentrumBerlin,Berlin,Germany; 3 ProfGiselaEnders &KollegenMVZGbR,Stuttgart,Germany; 4 InstofVirology,Univof Frankfurt,Frankfurt,Germany 526 HCV Ag Core’s Screening Performance in Mono- Infected, HIV- and HBV-Coinfected Patients Léa Duchesne 1 ; Richard Njouom 2 ; Frédéric L. Lissock 2 ; Ghislaine FloreTamko-Mella 2 ; Alexandre Soulier 3 ; Stephane Chevaliez 3 ; Karine LaCombe 4 ; Nicolas Rouveau 5 ; Lila Poiteau 3 ; Sandrine Rallier 6 1 INSERM,UMR-S1136,Paris,France; 2 InstPasteurofCameroon, Yaounde,Cameroon; 3 INSERMU955,Créteil,France; 4 SorbonneUnivs, Paris,France; 5 NatlAgencyofRsronAIDSandViralHepatitis,Paris, France; 6 NatlReferenceCntr forViralHepatitisB,CandDelta,HospHenri Mondor,UnivParis-Est,Créteil,France 2:45 PM-4:00 PM Acute HCV Infection 590 Incidence/Deaths Related to Acute Hepatitis C in Spain: Impact of HIV/HCV Coinfection Alejandro Alvaro-Meca 1 ; Asuncion Diaz 2 ; Marta Sánchez-Carrillo 2 ; SoniaVázquez-Morón 2 ; Salvador Resino 2 ; Verónica Briz 2 1 UnivRey JuanCarlos,Alcorcón,Spain; 2 InstdeSaludCarlos III,Madrid, Spain 2:45 PM-4:00 PM Hepatitis A, D, and E 591 Hepatitis A Virus Vaccination and Immunity Among at Risk HIV-Infected Adults Nicholas P. DeGroote 1 ; Christine Mattson 1 ;YunfengTie 2 ; JohnT. Brooks 1 ; Shikha Garg 1 1 CDC,Atlanta,GA,USA; 2 ICF Intl,Atlanta,GA,USA 592 Antiretroviral Therapy and Hepatitis Delta Replication in HIV-Coinfected Patients Charles Béguelin 1 ; Darius Moradpour 2 ; Roland Sahli 3 ; Huldrych F. Günthard 4 ; Manuel Battegay 5 ; Alexandra L. Calmy 6 ; Enos Bernasconi 7 ; Andri Rauch 1 ; GillesWandeler 8 ; for the Swiss HIV Cohort Study 1 BernUnivHospandUnivofBern,Bern,Switzerland; 2 CHUVaudois,Univ ofLausanne,Lausanne,Switzerland; 3 InstofMicrobiology,CHUVaudois, UnivofLausanne,Lausanne,Switzerland; 4 UnivHospZurich,Zurich, Switzerland; 5 UnivHospBasel,Basel,Switzerland; 6 UnivHospGeneva, UnivofGeneva,Geneva,Switzerland; 7 RegionalHospLugano,Lugano, Switzerland; 8 UnivHospBern,Bern,Switzerland Session P-N8 Poster Abstracts Hall A/B Session P-N9 Poster Abstracts Hall A/B

Takeo Kuwata 1 ; Ikumi Enomoto 1 ; Masanori Baba 2 ; Shuzo Matsushita 1 1 KumamotoUniv,Kumamoto, Japan; 2 KagoshimaUniv,Kagoshima, Japan 505 Molecular Dynamics of the CD4-Mimetic Resistant HIV-1 Gp120 by MD Simulation Shigeyoshi Harada 1 ; MasaruYokoyama 2 ; Shuzo Matsushita 3 ; Hironori Sato 2 ;Tetsuro Matano 1 ; KazuhisaYoshimura 1 1 Natl Instof InfectiousDiseases,Shinjuku, Japan; 2 Natl Instof Infectious Diseases,Musashimurayama, Japan; 3 KumamotoUniv,Kumamoto, Japan 506 Suppress NNRTI-Resistant Mutants by Doravirine at Clinically Relevant Concentrations Ming-Tain Lai ; Nancy Sachs; MeiZhen Feng; Min Xu; Jay Grobler; Wade Blair; Mike Miller; Daria J. Hazuda Merck&Co, Inc,WestPoint,PA,USA 507 The Effect of E157Q in HIV-1 Integrase on R263K- Mediated Dolutegravir Resistance Kaitlin Anstett 1 ;Vincent Cutillas 2 ; Robert Fusco 1 ;Thibault Mesplede 2 ; Bonnie A. Spira 2 ; Mark A.Wainberg 2 1 McGillUniv,Montreal,QC,Canada; 2 McGillUnivAIDSCntr,Montreal, QC,Canada 2:45 PM-4:00 PM HIV-2 Drug Resistance 508 Drug Resistance Mutations in HIV-2 Patients Failing Raltegravir and Dolutegravir Silvia Requena 1 ; Carmen de Mendoza 2 ;Teresa Cabezas 3 ; Rosa García 4 ; Maria Jose Amengual 5 ; Ana Belen Lozano 3 ; Juan Manuel Fernandez 3 ; Vicente Soriano 6 ; AnaTreviño 7 ; for the Spanish HIV-2 Study Group 1 PuertadeHierroRsr Inst,Majadahonda,Spain; 2 LaPazUnivHosp, Madrid,Spain; 3 HospdePoniente,Almería,Spain; 4 HospUniversitario Fundación JiménezDíaz,Madrid,Spain; 5 CorporaciónSanitariaParc Taulí,Barcelona,Spain; 6 HospLaPaz,Madrid,Spain; 7 HospUniversitario PuertadeHierrodeMadrid,Madrid,Spain 509 Prevalence of Minority Resistant Variants in HIV-2 Naïve Patients: ANRS CO5 Cohort Alexandre Storto 1 ; BenoitVisseaux 2 ; Gilles Collin 1 ; Catherine Fagard 3 ; Marine Naudin 3 ; Florence Damond 1 ; Marie-Aude Khuong 4 ; Sophie Matheron 1 ; Diane Descamps 5 ; Charlotte Charpentier 2 1 HospBichat-ClaudeBernard,Paris,France; 2 INSERMUMR1137, Paris,France; 3 CMG-ECde l’INSERMU897,Bordeaux,France; 4 Hosp Delafontaine,Paris,France; 5 HospBichat-ClaudeBernard,Päris,France Session P-L4 Poster Abstracts Hall A/B

Poster Listings

CROI 2016 112